Tocilizumab for Treatment of Steroid Refractory Acute Graft-versus-Host Disease
Status:
Terminated
Trial end date:
2018-09-29
Target enrollment:
Participant gender:
Summary
This trial designed to evaluate the toxicity and efficacy of tocilizumab in the treatment of
steroid refractory acute graft versus host disease (GVHD).